Page last updated: 2024-12-08
5-o-methyl-myo-inositol
Description
1D-5-O-methyl-myo-inositol : A member of the class of methyl myo-inositols that is cyclohexane-1,2,3,4,5-pentol substituted by a methoxy group at position 6 (the 1R,2S,3r,4R,5S,6r-stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 439990 |
CHEMBL ID | 460057 |
CHEBI ID | 179104 |
CHEBI ID | 15975 |
SCHEMBL ID | 1888646 |
SCHEMBL ID | 7155914 |
SCHEMBL ID | 1059036 |
MeSH ID | M0574056 |
Synonyms (36)
Synonym |
(1s,2r,4s,5r)-6-methoxycyclohexane-1,2,3,4,5-pentol |
CHEBI:179104 |
(1r,2s,3r,4r,5s,6r)-6-methoxycyclohexane-1,2,3,4,5-pentol |
CHEBI:15975 |
o-methyl-scyllo-inositol |
C03365 |
523-92-2 |
1d-5-o-methyl-myo-inositol |
C05163 |
sequoyitol |
1-o-methyl-scyllo-inositol |
5-o-methyl-myo-inositol , |
6A797581-AC95-4A84-9F74-C05E5465011A |
BMSE000740 |
(1r,2s,4r,5s)-6-methoxycyclohexane-1,2,3,4,5-pentol |
CHEMBL460057 |
AKOS006272498 |
SCHEMBL1888646 |
SCHEMBL7155914 |
S9343 |
myo-inositol, 5-o-methyl- |
einecs 208-352-9 |
SCHEMBL1059036 |
AC-32615 |
2-o-methyl-myo-inositol |
(1r,2s,3r,4r,5s,6r)-6-methoxycyclohexane-1,2,3,4,5-pentaol |
(+)-3-o-methyl-d-chiro-inositol |
HY-N2421 |
Q27098326 |
CCG-266528 |
CS-0022628 |
MS-23046 |
(1r,2s,4r,5s)-6-methoxycyclohexane-1,2,3,4,5-pentaol |
DTXSID801313753 |
7600-53-5 |
E80607 |
Drug Classes (1)
Class | Description |
cyclohexanols | An alcohol in which one or more hydroxy groups are attached to a cyclohexane skeleton. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 13.06 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 5.37 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |